MYOSIN HBD3 SOFTGEL

Composition: Ferrous Aspartoglycinate 100mg + L Methylfolate Calcium 1000mcg + Mecobalamin 1500mcg + Pyridoxal-5-Phosphate 0.5mg + Cholecalciferol 2000IU (capsules). In this combination, Ferrous Aspartoglycinate (oral iron), L-Methylfolate (active folate), Methylcobalamin (active vitamin B12), Pyridoxal-5-Phosphate (active vitamin B6) and Vitamin D3 (vitamin D) are paired so that their mechanisms work alongside one another.

Ferrous aspartoglycinate is an amino-acid-chelated oral iron. L-methylfolate is the active form of folate. Methylcobalamin is the active coenzyme form of vitamin B12, involved in nerve function and haematopoiesis. Pyridoxal-5-phosphate is the active coenzyme form of vitamin B6. Cholecalciferol (vitamin D3) supports calcium absorption and bone health.

MYOSIN-HBD3 is a prescription medicine from Aerochem Neutron's haematinic range, for use on the prescription of a registered medical practitioner.

·       Contains Ferrous Aspartoglycinate 100mg + L Methylfolate Calcium 1000mcg + Mecobalamin 1500mcg + Pyridoxal-5-Phosphate 0.5mg + Cholecalciferol 2000IU

·       Ferrous aspartoglycinate — amino-acid-chelated oral iron

·       L-methylfolate is the active form of folate

·       Methylcobalamin is the active coenzyme form of vitamin B12, involved in nerve function and haematopoiesis

·       Pyridoxal-5-phosphate is the active coenzyme form of vitamin B6

·       Cholecalciferol (vitamin D3) supports calcium absorption and bone health

·       Presented as Softgel capsules

·       Iron deficiency anaemia

·       Anaemia in pregnancy and lactation

·       Iron and vitamin D deficiency

·       Note: indications reflect established uses of the individual molecules; confirm against the CDSCO-approved label for this fixed-dose combination

Safety

·       Contraindicated in patients with known hypersensitivity to any component.

·       Oral iron may cause gastrointestinal upset and dark stools; keep out of reach of children.

·       High-dose vitamin D should be used only for confirmed deficiency; monitor for hypercalcaemia.

·       Pregnancy and lactation: use only if the prescriber judges the benefit to outweigh the risk.

Clinical Rationale: Evidence summary for Ferrous Aspartoglycinate, L-Methylfolate, Methylcobalamin, Pyridoxal-5-Phosphate, Vitamin D3: reference verification pending. Use of the combination should follow the CDSCO-approved label for this fixed-dose combination.